Foundation Program Sites

Alzheimer’s and Other Dementias Revision

Join our conversation

In person

If you are unable to join with the below options, there will be a physical space reserved in the Foundation for Health Care Quality’s Seattle office to participate in the virtual meeting at the below address:


Industrious 400U @ Rainier Square
400 University Street
Floor 3
Seattle, WA 98101

Directions to FHCQ Office

Online

Meeting ID: 255 943 922 673 8
Passcode: eK6Nf7Mn

Background

As the population continues to age quickly, the risk Alzheimer’s disease and other dementias increases. In 2020, there were around 125,116 people living with dementia, including Alzheimer’s disease, in Washington state. By 2040, this number is expected to exceed 270,000 people.[i] Individuals living with dementia are hospitalized 2-3 times as often as people of the similar age who do not live with dementia, and estimated cost of medical care for people living with dementia in 2019 was around $50,000.[ii] Washington Medicare beneficiaries living with dementia are significantly more costly than beneficiaries without dementia ($2,229 Per Member Per Month (PMPM) versus $803 PMPM). Early diagnosis is associated with a per-person savings of on average $64,000. People who identify with historically underserved or minoritized populations are less likely than those who identify as White to be diagnosed, are usually diagnosed at a later stage, are less likely to use hospice care, and have a higher risk of hospitalization.[iii] Many people also experience mild cognitive impairment (MCI) that can progress to dementia,[iv] and new biomarker testing strategies can indicate people at higher risk with and without mild cognitive impairment.[v] Since the original Bree Collaborative repot, new evidence has emerged around modifiable risk factors, testing and diagnosis, treatments, care strategies, and payment methodologies, as well as a new Washington State Plan to Address Alzheimer’s Disease and Other Dementias. Updating and aligning recommendations could  enhance practices in preventing, diagnosing and treating dementia to improve outcomes and provide cost savings for all Washingtonians.

Next Meeting Time Materials
Jan 26th, 2026 2:30-4:00pm Please see below

Meeting Materials

Date Materials
January 26th January Agenda
Draft Charter
Draft Workplan
February 9th February Agenda
January Minutes
Draft Workplan / Evidence Table
March 9th March Agenda
February Minutes
Evidence Table / Materials
April 20th April Agenda
March Minutes
Evidence Table / Materials
May 11th May Agenda
April Minutes
Evidence Table / Materials
June 8th June Agenda
May Minutes
Evidence Table / Materials
July 20th July Agenda
June Minutes
Evidence Table / Materials
August 10th August Agenda
July Minutes
Evidence Table / Materials
September 14th September Agenda
August Minutes
Evidence Table / Materials
October 12th October Agenda
September Minutes
Evidence Table / Materials
November 9th November Agenda
October Minutes
Evidence Table / Materials
December 14th December Agenda
November Minutes
Evidence Table / Materials
 

Workgroup Members

Name Title Organization
Kristoffer Rhoads, PhD, (chair) Associate Professor | Neuropsychologist | Co-Leader, Project ECHO Dementia University of Washington | Memory and Brain Wellness Center | UW ADRC Clinical Core
Jamie Tueteberg, MS Director of Healthy Aging Initiatives | Health and Aging Policy Fellow Washington Health Care Authority
Katina Rue, DO, FAAFP, FACOFP Medical Director Team Health
Carla Ainsworth, MD Family Medicine Residency Program Director Kaiser Permanente
Allyson Schrier Caregiver Advocate  
Carroll Haymon, MD Physician Faculty | Clinical Advisor and Consultant Providence Swedish | AC Haymon Consulting
Rodney Anderson, MD President/Chief Executive Officer Family Care Network
Cathy McCaul, MA Advocacy Director American Association of Retired Persons (AARP) Washington
Laura Cepoi, MA Executive Director Olympic Area Agency on Aging
Cathy Cooper, MSW, LICSW Palliative Care Social Worker Multicare
LuPita Gutierrez-Parker Patient Advocate  
Vicki McNealley, PhD, MN, RN Director of Assisted Living Washington Health Care Association
Lynne Korte, MPH Dementia Care Policy and Program Analyst/Manager Washington Department of Social and Health Services
Nancy Isenberg, MD Medical Director | Center for Healthy Aging Swedish Neuroscience Institute
Maureen Schmitter-Edgecombe, PhD Regents Professor Washington State University

[i] Washington State Department of Social and Health Services. (2023). Washington State Plan to Address Alzheimer’s Disease and Other Dementias 2023-2028. https://www.dshs.wa.gov/sites/default/files/ALTSA/stakeholders/documents/AD/Washington%20State%20Plan%20to%20Address%20Alzheimer%E2%80%99s%20Disease%20and%20Other%20Dementias%202023-28.pdf

[ii] Lastuka A, Breshock MR, Taylor KV, Dieleman JL. The costs of dementia care by US state: Medical spending and the cost of unpaid caregiving. Journal of Alzheimer’s Disease. 2025;105(1):186-196. doi:10.1177/13872877251326231

[iii] Hinton, L., Tran, D., Peak, K., Meyer, O. L., & Quiñones, A. R. (2024). Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review. Alzheimer’s and Dementia, 20(4), 3000–3020. https://doi.org/10.1002/alz.13612

[iv] Salemme S, Lombardo FL, Lacorte E, Sciancalepore F, Remoli G, Bacigalupo I, Piscopo P, Zamboni G, Rossini PM, Cappa SF, Perani D, Spadin P, Tagliavini F, Vanacore N, Ancidoni A. The prognosis of mild cognitive impairment: A systematic review and meta-analysis. Alzheimers Dement (Amst). 2025 Mar 12;17(1):e70074. doi: 10.1002/dad2.70074. Erratum in: Alzheimers Dement (Amst). 2025 Jul 18;17(3):e70150. doi: 10.1002/dad2.70150. PMID: 40078377; PMCID: PMC11898010.

[v] Huszár, Z., Engh, M., Pavlekovics, M. et al. Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis. Alz Res Therapy 16, 81 (2024). https://doi.org/10.1186/s13195-024-01455-2